
Virtual CME Program
COVID-19 Web Series Part 11: Recent Retractions, Post-exposure Prophylaxis, and Viral Shedding
In the eleventh episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss recent publications and issues related to COVID-19 including the retraction of two major trials on hydroxychloroquine from Lancet and NEJM, the results of a trial investigating hydroxychloroquine as post-exposure prophylaxis for COVID-19, and the results of a study investigating transmission and viral shedding of COVID-19.
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 6/10/2020
Expiration Date: 6/10/2021
Topics
Learning Objectives
- Describe recent retractions from two major publications around hydroxychloroquine treatment in COVID-19
- Review recent research on the role of hydroxycholorquine as post-exposure prophylaxis for COVID-19
- Discuss recent research on transmission and viral shedding of COVID-19
Faculty

Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence St. Joseph Health
Portland, OR

Charles Vega, MD, FAAFP
Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Assistant Dean for Culture and Community Education
Executive Director, UC Irvine Program in Medical Education for the Latino Community
UC Irvine School of Medicine
Irvine, CA
Learn More
Supporters and Partners
Supported by
Not Applicable
Education Partner
Not Applicable